<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.pharmaradar360.com/article/6867a9881ffb4123</loc><news:news><news:publication><news:name>PharmaRadar360</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:00:00.000Z</news:publication_date><news:title>Neoadjuvant FOLFOXIRI chemotherapy with or without camrelizumab in the treatment of locally advanced rectal cancer: a retrospective cohort study</news:title></news:news></url></urlset>